GlobeNewswire: mdxhealth Contains the last 10 of 888 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T06:57:24ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/12/2844983/0/en/Mdxhealth-Adds-Hereditary-Prostate-Cancer-Genetic-Test-to-Prostate-Cancer-Offering.html?f=22&fvtc=4&fvtv=29782Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering2024-03-12T20:00:00Z<![CDATA[Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering]]>https://www.globenewswire.com/news-release/2024/03/06/2841752/0/en/Mdxhealth-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html?f=22&fvtc=4&fvtv=29782Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results2024-03-06T21:00:00Z<![CDATA[Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results]]>https://www.globenewswire.com/news-release/2024/02/21/2833183/0/en/MDxHealth-to-Present-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Corporate-Update-on-March-6.html?f=22&fvtc=4&fvtv=29782MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 62024-02-21T22:00:00Z<![CDATA[MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6]]>https://www.globenewswire.com/news-release/2024/02/16/2830770/0/en/Mdxhealth-Announces-Resignation-of-Board-Member.html?f=22&fvtc=4&fvtv=29782Mdxhealth Announces Resignation of Board Member2024-02-16T13:45:00Z<![CDATA[Mdxhealth Announces Resignation of Board Member]]>https://www.globenewswire.com/news-release/2024/01/08/2805835/0/en/MDxHealth-Reports-Preliminary-Fourth-Quarter-and-Full-Year-2023-Revenues-and-Issues-2024-Revenue-Guidance.html?f=22&fvtc=4&fvtv=29782MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance2024-01-08T21:00:00Z<![CDATA[]]>https://www.globenewswire.com/news-release/2023/12/18/2797458/0/en/MDxHealth-Announces-Completion-of-Transition-to-Single-Listing-on-Nasdaq.html?f=22&fvtc=4&fvtv=29782MDxHealth Announces Completion of Transition to Single Listing on Nasdaq2023-12-18T06:00:00Z<![CDATA[NEWS RELEASE – REGULATED INFORMATIONDECEMBER 18, 2023, 1:00 AM ET / 07:00 AM CET]]>https://www.globenewswire.com/news-release/2023/12/18/2797458/0/fr/MDxHealth-annonce-la-r%C3%A9alisation-de-sa-transition-vers-une-cotation-unique-sur-le-Nasdaq.html?f=22&fvtc=4&fvtv=29782MDxHealth annonce la réalisation de sa transition vers une cotation unique sur le Nasdaq2023-12-18T06:00:00Z<![CDATA[COMMUNIQUÉ DE PRESSE - INFORMATION RÉGLEMENTÉE18 DECEMBRE 2023, 01:00 ET / 07:00 CET]]>https://www.globenewswire.com/news-release/2023/11/27/2785832/0/en/MDxHealth-Announces-Completion-of-Mandatory-ADS-Exchange-and-Commencement-of-Transition-Period-to-Single-Listing-on-Nasdaq.html?f=22&fvtc=4&fvtv=29782MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq2023-11-27T06:00:00Z<![CDATA[NEWS RELEASE – REGULATED INFORMATIONNOVEMBER 27, 2023, 1:00 am ET / 7:00 am CET]]>https://www.globenewswire.com/news-release/2023/11/27/2785832/0/fr/MDxHealth-annonce-la-r%C3%A9alisation-de-l-%C3%A9change-obligatoire-d-ADS-et-le-d%C3%A9but-de-la-p%C3%A9riode-de-transition-vers-une-cotation-unique-sur-le-Nasdaq.html?f=22&fvtc=4&fvtv=29782MDxHealth annonce la réalisation de l'échange obligatoire d'ADS et le début de la période de transition vers une cotation unique sur le Nasdaq2023-11-27T06:00:00Z<![CDATA[COMMUNIQUÉ DE PRESSE - INFORMATION RÉGLEMENTÉE27 NOVEMBRE 2023, 1:00 EDT / 7:00 CET]]>https://www.globenewswire.com/news-release/2023/11/14/2780474/0/en/MDxHealth-to-Participate-in-the-35th-Annual-Piper-Sandler-Healthcare-Conference.html?f=22&fvtc=4&fvtv=29782MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference2023-11-14T21:00:00Z<![CDATA[]]>